Combination therapy
    6.
    发明授权
    Combination therapy 有权
    联合治疗

    公开(公告)号:US09408847B2

    公开(公告)日:2016-08-09

    申请号:US14646206

    申请日:2013-11-25

    摘要: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明涉及药物组合,其包含(1)作为CDK抑制剂或其药学上可接受的盐的第一药剂和(2)作为mTOR抑制剂或其药学上可接受的盐的第二药剂。

    COMBINATION THERAPY
    7.
    发明申请
    COMBINATION THERAPY 有权
    组合治疗

    公开(公告)号:US20150306104A1

    公开(公告)日:2015-10-29

    申请号:US14646206

    申请日:2013-11-25

    IPC分类号: A61K31/519 A61K31/436

    摘要: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明涉及药物组合,其包含(1)作为CDK抑制剂或其药学上可接受的盐的第一药剂和(2)作为mTOR抑制剂或其药学上可接受的盐的第二药剂。